Trials / Completed
CompletedNCT01367457
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Inhibitor - Estudio Retrospectivo De Casos Clinicos De Pacientes Con Carcinoma De Celulas Renales Y Con Linforma De Celulas Del Manto Tratados Con Temsirolimus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 243 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The principal objective of the study is to evaluate the efficacy and safety of temsirolimus use in patients with Renal Cell Carcinoma and Mantle Cell Lymphoma.
Detailed description
There is not sampling method
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Temsirolimus (Non-Interventional Study) | There is not any intervention in this study. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2011-06-07
- Last updated
- 2016-04-27
- Results posted
- 2016-04-27
Locations
16 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01367457. Inclusion in this directory is not an endorsement.